FDA Approves Cancer Drug That Got Standing Ovation

When Revolution Medicines shared the results of its pancreatic cancer drug at one of the preeminent meetings of cancer researchers in the spring, a nearly minute-long standing ovation followed, reports the Wall Street Journal . Now, reason for more cheers: The FDA approved the drug on Wednesday, marking "a milestone in...